Our patients probably have low real prevalence of advanced fibrosis which is likely overestimated by LSM ≥ 9.6 kPa. Liver fibrosis may be safely reassessed in the 2 years interval in noncirrhotic patients with T2D.

In a cohort of T2D patients, no liver-related morbidity or mortality occurred during 2 years. Our patients probably have low rea…[Read more]